An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
Perimeter Medical Imaging AI to Host Conference Call and Webcast to Discuss Fourth Quarter and Year-End 2021 Financial Results and Provide Corporate Update
Perimeter Medical Imaging AI (TSX-V:PINK)(OTC:PYNKF) announced a conference call to discuss its financial results for the year ending December 31, 2021, scheduled for May 3, 2022 at 5:00 pm ET. The call aims to provide insights into the company's performance in transforming cancer surgery with advanced imaging tools. Investors can join the call via phone or audio webcast.
Positive
The company's advanced imaging tools address high unmet medical needs in cancer surgery.
The FDA-cleared Perimeter S-Series OCT imaging system enhances real-time visualization of excised tissues.
Negative
None.
Live Call/Audio Webcast to Begin at 5:00 pm ET Today
TORONTO & DALLAS--(BUSINESS WIRE)--
Perimeter Medical Imaging AI, Inc. (TSX-V:PINK)(OTC:PYNKF) (FSE:4PC) (“Perimeter” or the “Company”), a medical technology company driven to transform cancer surgery with ultra-high-resolution, real-time, advanced imaging tools to address high unmet medical needs, announced it will host a conference call to discuss its financial results for the year ended December 31, 2021 today at 5 pm ET.
Details on company presentations and webcasts can be found on the “Investors” section of Perimeter’s website at https://ir.perimetermed.com/. When available, webcasts will be posted for replay following the event. The above listed dates and times are subject to change.
About Perimeter Medical Imaging AI, Inc. Based in Toronto, Canada and Dallas, Texas, Perimeter Medical Imaging AI (TSX-V:PINK) (OTC:PYNKF) (FSE:4PC) is a medical technology company driven to transform cancer surgery with ultra-high-resolution, real-time, advanced imaging tools to address areas of high unmet medical need. Available across the United States, our FDA-cleared Perimeter S-Series OCT imaging system provides real-time, cross-sectional visualization of excised tissues at the cellular level. The breakthrough-device-designated, investigational Perimeter B-Series OCT with ImgAssist AI represents our next-generation artificial intelligence technology that is currently under clinical development. The company’s ticker symbol “PINK” refers to the pink ribbons used during Breast Cancer Awareness Month.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Shushu Feng
Perimeter Medical Imaging AI, Inc. Direct: 647-339-7465 (PINK)
Toll-free: 888-988-7465 (PINK)
investors@perimetermed.com
Source: Perimeter Medical Imaging AI, Inc.
FAQ
When will Perimeter Medical Imaging AI discuss its 2021 financial results?
Perimeter Medical Imaging AI will discuss its 2021 financial results on May 3, 2022, at 5:00 pm ET.
What is the ticker symbol for Perimeter Medical Imaging AI?
The ticker symbol for Perimeter Medical Imaging AI is PINK on TSX-V and PYNKF on OTC.
How can I join the Perimeter Medical Imaging AI conference call?
You can join the Perimeter Medical Imaging AI conference call by calling 1-877-704-4453 (Canada and U.S.) or 1-201-389-0920 (International).
What technology does Perimeter Medical Imaging AI use for cancer surgery?
Perimeter Medical Imaging AI uses the Perimeter S-Series OCT imaging system, which provides real-time, cross-sectional visualization of excised tissues at the cellular level.
